Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
BMC Bioinformatics|April 23, 2025
HPOseq: a deep ensemble model for predicting the protein-phenotype relationships based on protein sequencesKai Zhao, Zhuocheng Ji, Linlin Zhang, et al.
Iscience|April 17, 2026
Brain age gap as biomarker linking cardiovascular diseases genetic susceptibility and causalityShangying Lyu, Ruixia Zhang, Kai Peng, et al.
Clinical Trials (London, England)|November 7, 2022
Strategies to facilitate adolescent access to medicines: Improving regulatory guidanceChristina Bucci-Rechtweg, Angeliki Siapkara, Kristina An Haack Bonnet, et al.
Pharmaceutical Statistics|April 28, 2017
Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluationMargaret Gamalo-Siebers, Jasmina Savic, Cynthia Basu, et al.
Clinical Pharmacology and Therapeutics|February 5, 2020
Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a WorkshopJeffrey S Barrett, Christina Bucci-Rechtweg, S Y Amy Cheung, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|March 8, 2026
Mechanisms of heat and hypoxia defense in the sea cucumber Apostichopus japonicus: Insights from ubiquitination regulationBin Xia, Jingwen Song, Qian Xin, et al.
JAMA Dermatology|August 9, 2023
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 TrialsJustin M Ko, Tiffany T Mayo, Wilma F Bergfeld, et al.
The British Journal of Dermatology|April 3, 2025
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with BaricitinibArash Mostaghimi, Brittany Craiglow, Brett King, et al.
Environmental Geochemistry and Health|March 14, 2025
Hydrochemical insights into spatiotemporal characteristics of groundwater salinization and health risk assessment of fluoride in the south bank of Yellow River irrigation area, Northwest ChinaMuhan Li, Shen Qu, Guanglei Yu, et al.
The American Journal of Gastroenterology|March 13, 2025
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 StudyScott D Lee, Severine Vermeire, Ryan Ungaro, et al.
Pageof 9